Baillie Gifford started to build up the position in Ultragenyx Pharmaceutical in Q4 2020 and continued to invest until Q1 2021. Since then they sold 115 shares. The investor sold all their shares in Q2 2023 and doesn't own any shares in Ultragenyx Pharmaceutical anymore.